Humans Are Progressing Despite The Gloomy News Flow: Pinker

Humans Are Progressing Despite The Gloomy News Flow: Pinker

Steven Pinker, Harvard psychologist and professor, discusses his new book, "Enlightenment Now: The Case for Reason, Science, Humanism and Progress."Paresh Upadhaya, Director of Currency Strategy at Amundi Pioneer, on how the dollar will perform going forward under a protectionist agenda, and his favorite FX trade for 2018.Beatrice Fihn, Executive Director of the International Campaign to Abolish Nuclear Weapons (ICAN), discusses a report that reveals what companies benefit from a new arms race.Vincent Piazza, Senior Equity Energy Analyst and Global Sector Leader for Bloomberg Intelligence, on oil, US shale overtaking OPEC, and what E&P companies will do with their excess cash.

See omnystudio.com/listener for privacy information.

Jaksot(3349)

Largest NY Hospital System Sees Return of Patients, Surgeries

Largest NY Hospital System Sees Return of Patients, Surgeries

Michael Dowling, President and CEO of Northwell Health, on how New York State’s largest hospital system is faring as the state begins reopening. Sarah Halzack, Bloomberg Opinion retail columnist, to d...

11 Kesä 202029min

We're Looking At A Secular Shift To Lower Rates: PGIM's Tipp

We're Looking At A Secular Shift To Lower Rates: PGIM's Tipp

Robert Tipp, Chief Investment Strategist at PGIM, discusses fixed income markets and Fed stimulus. Jonathan Bernstein, Bloomberg Opinion politics columnist, on his column: "Be Ready for a Long Electio...

10 Kesä 202027min

Why Military Leaders Like Me Are Speaking Out: James Stavridis

Why Military Leaders Like Me Are Speaking Out: James Stavridis

Retired Navy Admiral James Stavridis, former military commander of NATO and a Bloomberg Opinion columnist, discusses his column: "Why Military Leaders Like Me Are Speaking Out." Tara Lachapelle, Bloom...

9 Kesä 202028min

Not Much Strategic Sense To An AstraZeneca-Gilead Deal

Not Much Strategic Sense To An AstraZeneca-Gilead Deal

Bloomberg Opinion's Max Nisen, biotech and health care columnist, and Chris Hughes, deals columnist, on AstraZeneca mulling a bid for Gilead. Bill Smead, CEO and CIO of Smead Capital Management, on bu...

8 Kesä 202028min

Troubling Signs Lurk Within Shocking Job Gains: LaSalle CEO

Troubling Signs Lurk Within Shocking Job Gains: LaSalle CEO

Tom Gimbel, CEO of global staffing company LaSalle Network, dissects the unexpectedly strong jobs report. Danielle DiMartino Booth, CEO and Chief Strategist at Quill Intelligence LLC, Bloomberg Opinio...

5 Kesä 202034min

A Real Leader Is Needed To Deliver Vital Changes: David McCourt

A Real Leader Is Needed To Deliver Vital Changes: David McCourt

David McCourt, Founder and CEO of Granahan McCourt Capital and Chairman of National Broadband Ireland, discusses the need for a great leader in times of crisis. Mary Schlangenstein, U.S. Airlines Repo...

4 Kesä 202029min

Yes, Trump Can Send In The Military But Probably Won't: Feldman

Yes, Trump Can Send In The Military But Probably Won't: Feldman

Noah Feldman, Harvard Law professor and Bloomberg Opinion columnist, discusses his column: "Can Trump Send In the Military? Probably, Yes." Yelena Shulyatyeva, Senior U.S. Economist for Bloomberg Econ...

3 Kesä 202029min

It's A Borrower's Bond Market, As Amazon Scores Record Low Rates.

It's A Borrower's Bond Market, As Amazon Scores Record Low Rates.

Molly Smith, corporate finance reporter for Bloomberg, on why it's a borrower's bond market. John Streur, CEO of Calvert Research and Management, discusses why ending racism in America is a responsibi...

2 Kesä 202029min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
rss-rahamania
taloudellinen-mielenrauha
ostan-asuntoja-podcast
herrasmieshakkerit
rahapuhetta
juristipodi
rss-draivi
rss-sami-miettinen-neuvottelija
asuntoasiaa-paivakirjat
rss-lahtijat
rss-seuraava-potilas
rss-paasipodi
pomojen-suusta
rss-h-asselmoilanen
rss-rikasta-elamaa
rss-markkinointitrippi